Kratom law update · Adults 21+ · Verified September 3, 2026
Is 7-OH Banned? Federal DEA and Florida Status in 2026
The accurate answer is “partly.” Three related compounds are already Schedule I federally. The separate federal proposal for 7-OH above defined thresholds remains pending. Florida already controls 7-OH products that cross its state thresholds.
Featured answer: Is 7-OH banned now?
As of September 3, 2026, 7-OH itself is not federally scheduled under the pending DEA threshold proposal. Mitragynine pseudoindoxyl, MGM-15, and MGM-16 have been Schedule I federally since August 26. Florida separately controls 7-OH above state thresholds. The federal comment period for thresholded 7-OH runs through September 10.
A threshold-based Schedule I action is proposed, not yet effective on this verification date.
MGPI, MGM-15, and MGM-16 became federally controlled on August 26.
Rule 2ER26-2 controls thresholded 7-OH and three separately named compounds.
Review the Federal Register again after the September 10 comment deadline.
Quick decision guide for buyers, sellers, and travelers
| What you plan to do | What matters federally | What matters in Florida | What to verify first |
|---|---|---|---|
| Buy or order | The actual compound and product format matter. | State concentration and alkaloid-ratio tests can apply. | Current label, matching COA, seller, destination, and date checked |
| Sell or distribute | Schedule I controls already apply to three named compounds. | Rule 2ER26-2 separately names compounds and thresholded 7-OH. | Product-specific compliance and qualified legal guidance |
| Possess | “Kratom” is not a complete product identity. | Composition may change the legal result. | Batch-specific analytes, units, and current jurisdiction |
| Ship across state lines | Federal law and the product’s contents remain relevant. | Florida law is only one part of an interstate question. | Origin, destination, carrier rules, and current law at both endpoints |
| Travel with it | Retail availability does not prove federal legality. | Another state or locality may use a different rule. | Every jurisdiction on the trip and the exact product identity |
This table identifies questions to check. It is not a product-specific legal conclusion.
Online headlines often compress two federal actions into one “7-OH ban.” That shortcut creates the wrong answer. The August action scheduled three related compounds. A separate federal proposal addresses 7-OH above specified thresholds and was still pending when this article was verified.
Florida adds another layer. Its current emergency rule can control a product based on concentration or the ratio between mitragynine and 7-OH. That is why a label saying “kratom,” “natural,” or “extract” cannot answer the legal question by itself.
Related guide: Legal status and drug-testing policies are different questions. If testing is your concern, read our guide to kratom and drug tests.
Article note: Prepared by the Mary Jane’s Bakery Co Editorial Team. Legal and agency sources were last checked September 3, 2026. This is an editorial primary-source review, not a legal or medical review.
Commercial disclosure: Mary Jane’s Bakery Co is a retailer. Retail availability or a product link does not establish legality, FDA approval, safety, or suitability. The legal and safety statements below are linked to government and public-health sources.
1. Is 7-OH banned right now?
There is no accurate nationwide one-word answer. As of September 3, the DEA had proposed temporarily placing 7-hydroxymitragynine above defined thresholds into Schedule I. The separate order covering thresholded 7-OH had not yet taken effect.
Three related substances are already Schedule I federally: mitragynine pseudoindoxyl, MGM-15, and MGM-16. Florida also has a separate rule that places qualifying 7-OH products and three named compounds into Schedule I at the state level.
2. What became Schedule I on August 26, 2026?
The DEA’s August 26 temporary scheduling order placed these three substances into Schedule I:
- Mitragynine pseudoindoxyl, also shortened to MGPI or MP;
- MGM-15; and
- MGM-16.
The order took effect on August 26, 2026. It is scheduled to remain effective through August 26, 2028 unless extended, superseded, or replaced through another action. Federal Schedule I controls apply to activities involving the covered substances, including manufacture, distribution, and possession.
The order did not schedule 7-OH itself. The threshold-based 7-OH proposal is a separate proceeding. This distinction is the central correction missing from many early-August summaries.
MGPI, MGM-15, and MGM-16
7-OH above specified thresholds
3. Does the federal action ban natural kratom leaf?
No. The 2026 federal actions do not impose a blanket ban on all traditional botanical kratom leaf. The pending 7-OH proposal describes thresholds for botanical Mitragyna speciosa material and separate tests for processed or synthetic articles. The Justice Department also distinguished the scheduled manufactured compounds from traditional botanical kratom in its announcement.
That does not mean every item labeled “kratom” is outside the proposed rule. Extracts, concentrates, edibles, pressed pills, and synthetically produced articles may contain different amounts or forms of 7-OH. A marketing term such as “natural” does not prove composition.
Botanical kratom is not risk-free. The National Institute on Drug Abuse notes that research remains limited and that adverse effects, dependence, withdrawal, and drug interactions have been reported. Kratom has not been established as safe or effective for treating a medical condition.
Readers comparing plant products can review our kava versus kratom guide and our explanation of red, white, and yellow kratom. Those guides discuss product categories, not whether a specific batch is legally compliant.
4. What federal 7-OH thresholds are proposed?
The federal proposal in docket DEA-1570 describes proposed Schedule I coverage above the following levels:
| Material or article type | Proposed federal trigger | What a reader should notice |
|---|---|---|
| Botanical Mitragyna speciosa material | More than 0.050% 7-OH on a dry-weight basis | The measurement is tied to dry botanical material. |
| Synthetic alternative article | More than 0.050% by the applicable weight or volume measure, or more than 1.00 mg of 7-OH in the article | Both concentration and total amount per article may matter. |
| Processed kratom article, including an extract, concentrate, edible, or pressed pill | More than 0.050% by the applicable weight or volume measure, or more than 1.00 mg of 7-OH in the article | The product format and total amount cannot be ignored. |
These are proposed federal thresholds on this article’s verification date. HHS extended its information-and-comment period through September 10, 2026. That deadline does not automatically become the effective date of a Schedule I order.
5. How do the federal and Florida 7-OH units compare?
Percentages and milligrams per gram describe concentration in different forms. Mathematically, 0.050% by weight equals 0.5 milligrams per gram because one percent equals 10 milligrams per gram. Florida’s current mass-concentration test for a solid or powder is more than 1 milligram per gram.
Educational conversion:
0.050% × 10 = 0.5 mg/g
This conversion does not create a universal legal calculator. The proposed federal text distinguishes botanical material from processed and synthetic articles. It also includes a total-milligrams-per-article test for certain products. Florida separately uses mg/g, mg/mL, and an alkaloid-ratio test. Dry weight, liquid volume, total article amount, sampling, and laboratory reporting can all affect the analysis.
6. Is 7-OH banned in Florida and Miami?
Florida has a separate state rule. Emergency Rule 2ER26-2 superseded rule 2ER26-1 on August 18, 2026. It places 7-OH into Schedule I when a product meets any of the current tests described in the rule:
- more than 1 milligram of 7-OH per gram for a solid or powder, including encapsulated material;
- more than 1 milligram of 7-OH per milliliter for a liquid, including a beverage, extract, or tincture; or
- less than 100 parts mitragynine for every 1 part 7-OH by mass.
The same Florida rule separately lists 7-acetoxymitragynine, MGM-15, and MGM-16 in Schedule I. It is scheduled to expire June 30, 2027 unless later state action changes that timeline. The official rule page contains an apparent display error showing 2002 in one effective-date field; the filing date and history note identify August 18, 2026.
Older Florida summaries may still repeat a 400 ppm standard from the superseded emergency rule. That is not the current number in rule 2ER26-2. Always check the rule history and effective version instead of relying on a screenshot or an undated retailer summary.
For Miami customers, the practical answer is to check the product composition, current Florida rule, and any applicable local requirement. Our Wynwood, Miami location information can help with store questions, but retail availability does not prove that a product is lawful or appropriate for a particular person.
7. How do you check a kratom label and COA?
A certificate of analysis can provide useful product information, but only when it matches the batch and reports the relevant analytes in usable units. It is not a legal certificate and cannot replace current federal or state rules.
| Product format | Useful COA information | Why format matters | Stop and verify when |
|---|---|---|---|
| Botanical leaf or powder | 7-OH percentage or mg/g, dry-weight basis, mitragynine, batch number | The proposed botanical threshold uses dry weight. | The basis or batch identity is missing. |
| Powder capsules | Powder result, capsule fill weight, mg/g, and batch match | A capsule shell does not explain the material inside. | The report covers a different powder lot. |
| Extract or concentrate | 7-OH concentration, total amount, sample description, extraction format | Processed articles have separate proposed federal tests. | The label says “proprietary” but gives no analyte result. |
| Liquid, beverage, or tincture | mg/mL, total container volume, total 7-OH, batch number | Florida uses a specific liquid concentration test. | Only mg per serving appears and the serving volume is unclear. |
| Tablet, gummy, or shot | Total mg per article, concentration, count, and batch identity | The proposed federal text includes an amount-per-article test. | The COA reports only a composite sample with no unit count. |
| Unknown or synthetic blend | Full named analyte panel, method, reporting limit, and laboratory verification | Related manufactured compounds may have their own status. | Names, methods, or meaningful detection limits are absent. |
Seven COA checks that matter
- Match the batch. The lot number on the report should match the product.
- Match the sample name. A report for raw powder does not automatically describe a finished shot or tablet.
- Find 7-OH by its full name. Look for 7-hydroxymitragynine, not only a generic “total alkaloids” number.
- Read the units. Percent, mg/g, mg/mL, and mg per article answer different questions.
- Check mitragynine. Florida’s ratio test requires information about both mitragynine and 7-OH.
- Review the reporting limit. “Not detected” means the analyte was not found above the method’s reporting threshold; it is not always proof of absolute zero.
- Verify the laboratory. Look for a real laboratory name, report identifier, test date, method, and an independently verifiable report.
If you are researching conventional botanical formats rather than enhanced products, our kratom category shows the formats currently displayed by Mary Jane’s Bakery Co. Product visibility does not establish legal status, FDA approval, safety, or fitness for a particular use.
8. What is the 2026 7-OH timeline?
- July 1: DEA announces separate planned actions for thresholded 7-OH and three related compounds.
- July 6: The two notices publish in the Federal Register.
- August 18: Florida rule 2ER26-2 supersedes the earlier state emergency rule.
- August 26: MGPI, MGM-15, and MGM-16 become Schedule I federally.
- August 26: HHS extends the information-and-comment period for the separate 7-OH threshold proposal.
- September 10: Extended federal comment deadline for thresholded 7-OH.
- June 30, 2027: Scheduled expiration of Florida rule 2ER26-2 unless state action changes it.
- August 26, 2028: Scheduled end of the temporary federal order for the three related compounds unless extended or superseded.
The September 10 deadline is a procedural checkpoint, not a promised effective date. DEA may consider the submitted information before deciding whether to issue a temporary order. Readers should look for an actual agency or Federal Register document rather than treating a social-media date as law.
9. What are the safety concerns with 7-OH and kratom products?
The FDA recommends avoiding products containing added or enhanced 7-OH. Reported problems include dependence, anxiety, depression, gastrointestinal distress, insomnia, seizures, and withdrawal symptoms. FDA has not approved 7-OH for pain, anxiety, opioid withdrawal, or another medical use.
A 2026 CDC poison-center analysis identified 14,449 kratom-related exposure reports from 2015 through 2025. Reports rose from 258 in 2015 to 3,434 in 2025. These reports do not prove that one product or compound caused every outcome, and many cases involved more than one substance. They do support careful identification, avoidance of risky combinations, and fast access to professional help.
10. What happens after the September 10 deadline?
Federal officials can evaluate the information submitted during the extended period. DEA can then decide whether to issue a temporary scheduling order for 7-OH above the proposed thresholds. There is no reliable public basis for promising an exact decision date.
If an order is issued, this page’s featured answer, status cards, thresholds, timeline, FAQs, SEO description, and visible update date should change on the same day. If the proposed scope changes or the action does not proceed, this page should report that outcome just as clearly.
- September 3, 2026: Updated for the August 26 federal order, pending thresholded 7-OH proposal, September 10 deadline, Florida rule 2ER26-2, buyer action matrix, and COA checks.
- Next mandatory source check: September 11, 2026, or immediately after a new DEA, Federal Register, or Florida filing.
- Correction standard: Substantive corrections should identify what changed, the date, and the controlling primary source.
11. Official sources used for this 7-OH update
| Primary or authoritative source | What it supports | Checked |
|---|---|---|
| DEA July 1 announcement | Two separate planned federal actions | September 3, 2026 |
| U.S. Department of Justice announcement | Three-compound action and distinction from traditional botanical kratom | September 3, 2026 |
| Federal Register temporary order | Effective Schedule I status and period for MGPI, MGM-15, and MGM-16 | September 3, 2026 |
| Federal Register 7-OH proposal | Proposed federal thresholds and product categories | September 3, 2026 |
| HHS and Federal Register extension | September 10, 2026 information-and-comment deadline | September 3, 2026 |
| Florida Emergency Rule 2ER26-2 | Current Florida compounds, thresholds, rule history, and expiration | September 3, 2026 |
| FDA 7-OH consumer update | FDA product status, reported harms, and safety guidance | September 3, 2026 |
| CDC MMWR poison-center analysis | Kratom-related exposure reports and study limitations | September 3, 2026 |
| NIDA kratom overview | Research uncertainty, effects, dependence, withdrawal, and interaction context | September 3, 2026 |
| Poison Help | U.S. poison-center contact information | September 3, 2026 |
Frequently asked questions
Is 7-OH federally illegal right now?
No final federal Schedule I order for 7-OH itself had taken effect as of September 3, 2026. A threshold-based action remains pending. Mitragynine pseudoindoxyl, MGM-15, and MGM-16 became Schedule I federally on August 26.
When will the proposed federal 7-OH ban take effect?
No exact effective date had been announced for thresholded 7-OH as of September 3. The extended information-and-comment period ends September 10, but that deadline is not automatically an effective date. An actual DEA or Federal Register action would establish the next legal change.
What did the DEA schedule on August 26?
The temporary federal order covers mitragynine pseudoindoxyl, MGM-15, and MGM-16. It does not place 7-OH itself into Schedule I under the separate threshold proposal.
Does the federal action ban natural kratom leaf?
No blanket federal ban on all traditional botanical kratom leaf was created by these actions. The pending proposal describes a threshold for botanical material and separate tests for processed or synthetic articles. State and local rules can still be stricter.
Can I buy, possess, or ship 7-OH in Florida?
Do not answer that question from the front label alone. Florida rule 2ER26-2 places qualifying 7-OH products into Schedule I using concentration and alkaloid-ratio tests. Product composition, location, shipment endpoints, and current law must be checked before making a legal decision.
What should a 7-OH COA show?
Look for a matching product and batch number, named 7-hydroxymitragynine and mitragynine results, usable units such as percent, mg/g, mg/mL, or mg per article, the reporting limit, test method, laboratory identity, and report date. A COA provides composition evidence, not a legal guarantee.
Is 7-OH the same as mitragynine pseudoindoxyl?
No. 7-hydroxymitragynine and mitragynine pseudoindoxyl are different compounds. The 2026 federal actions place them on different procedural tracks, which is why combining their status creates an inaccurate answer.
Does “not federally scheduled” mean a 7-OH product is FDA legal?
No. DEA scheduling and FDA product status are different. FDA says products with added or enhanced 7-OH are not approved for medical use and are not lawful dietary-supplement or conventional-food ingredients.
Does kratom show up on a drug test?
Legal status and testing are separate questions. Routine panels may not name kratom, while targeted testing exists. Read our complete kratom testing guide for that issue.
The bottom line
The accurate September 3 answer is neither “everything is banned” nor “nothing changed.” MGPI, MGM-15, and MGM-16 are Schedule I federally. The separate threshold-based federal proposal for 7-OH remains pending. Florida already controls 7-OH products that cross its current concentration or ratio tests.
For any real buying, possession, shipping, or business decision, identify the exact product, read a matching batch COA, check the current federal and destination rules, and obtain qualified advice when the consequences matter. Return to this page after September 10 for the next source check.